We aimed to investigate if this newly discovered SMYD3–RNF113 methylation event is physiologic and can be detected in cells, notably in relevant SCLC cells where it could explain the role of SMYD3 in alkylation damage sensitivity. The gene discussed is SMYD3; the disease is small cell lung carcinoma.